HCC
IDXX icon

Hirtle Callaghan & Co’s Idexx Laboratories IDXX Stock Holding History

Hirtle Callaghan & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12
Closed -$1K – 661
2014
Q1 		$1K Sell
12
-2
-14% -$119 ﹤0.01% 600
2013
Q4 		$1K Hold
14
– – ﹤0.01% 581
2013
Q3 		$1K Buy
+14
New +$673 ﹤0.01% 588

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Hirtle Callaghan & Co's IDXX Position: Q2 2014 in Review

Hirtle Callaghan & Co sold out of Idexx Laboratories (IDXX) in Q2 2014, closing a stake of 12 shares — an estimated $1K sold.

Hirtle Callaghan & Co first reported a position in IDXX in Q3 2013 and held it in 3 quarters. The position peaked at $1K in Q1 2014. 306 funds tracked by Wall St. Rank hold IDXX as of Q2 2014.

  • Hirtle Callaghan & Co reported no remaining Idexx Laboratories position as of Q2 2014 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 12 Idexx Laboratories shares in Q2 2014, an estimated $1K.
  • Hirtle Callaghan & Co first reported a position in Idexx Laboratories in Q3 2013 and held it in 3 quarters.
  • Hirtle Callaghan & Co's Idexx Laboratories position peaked at $1K in Q1 2014.
  • 306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2014.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2014, filed 18 Jul 2014.